BioXcel starts U.S. Department of War-funded trial for stress treatment

Go back to BioXcel starts U.S. Department of War-funded trial for stress treatment
(NASDAQ: BTAI) Delayed: 1.30 --0 (-0%)
Previous Close $1.30    52 Week High
Open $1.30    52 Week Low
Day High $1.30    P/E N/A 
Day Low $1.30    EPS
Volume 8,847